Is Jack Ma back? Inside the rise, fall and return of China’s tech mogul

Is Jack Ma back? Inside the rise, fall and return of China’s tech mogul


Alibaba co-founder Jack Ma is widely regarded as one of China’s most prominent business figures, but his journey hasn’t been without setbacks.

Jack Ma is regarded as one of China’s most prominent business figures. 

His rise from a modest background to co-founding one of China’s earliest e-commerce companies brought both Alibaba and Ma global recognition. 

The journey has not been without setbacks, however. Ma’s sudden retreat from public view in 2020 sparked speculation about whether he had stepped away from the spotlight for good. 

Yet, in 2025, a public appearance alongside Chinese President Xi Jinping signaled a possible return to the tech industry. 
 
Watch “Built for Billions” with Arjun Kharpal to learn more about the rise, fall and return of Jack Ma. 



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More